Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bluegrass Vascular Technologies, Inc.

Latest From Bluegrass Vascular Technologies, Inc.

Medical Device Start-Up News, April 2012

This month we profile OvaScience, which has a new approach for treating infertility in older women, and Bluegrass Vascular, which offers an “inside-out” catheter for central venous access.

Medical Device

Bluegrass Vascular Technologies Inc.

Central venous catheters are commonly employed to deliver long-term dialysis, nutrition and chemotherapy, but nearly 10% of patients have an upper-extremity venous occlusion that renders the vein impenetrable by standard access techniques. When access is not possible through traditional “outside-in” routes, Bluegrass Vascular Technologies’ Surfacer system allows for central venous access through the femoral vein in the leg. The device features a bullet-shaped catheter tip with a proprietary side-exit needle that allows the physician to enter into the occlusion and create a new tissue channel, from the inside out.

Medical Device

Start-Up Previews, April 2012

This Month's Profile Group, Vaccine Investment Gets A Shot In The Arm, features profiles of Genocea Biosciences, Imaxio, Selecta Biosciences and TremRx. Plus these Start-Ups Across Health Care: Bluegrass Vascular Technologies, Haldor Advanced Technologies and Targovax.

BioPharmaceutical Medical Device

Vascular Access Technologies Inc.

Central venous access continues to be linked to an abnormally high risk of serious and life-threatening complications. Unintended damage to major organs results from the “blind” placement of a hollow needle through the patient’s skin and into the target vein. Vascular Access Technologies Inc. hopes to reduce complications with SAFECVAD, a novel steerable catheter that uses the femoral vein as its point of entry. It is observed under fluoroscopy as it follows a simple guided path to the jugular or subclavian vein, where it makes a visible “inside-out” exit at the exact desired location for central line catheter placement.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive